228 related articles for article (PubMed ID: 18928635)
1. [Recent progress of study on mechanism of immune thrombocytopenic purpura and its clinical treatment - review].
Lu XC; Zhu HL; Yao SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1232-6. PubMed ID: 18928635
[TBL] [Abstract][Full Text] [Related]
2. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
4. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
Latifzadeh SZ; Entezari V
Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
[TBL] [Abstract][Full Text] [Related]
5. [Individualizing treatment of refractory and relapsed ITP in adults and its development of study].
Huang Y; Li W; Yang B; Zhu HL; Dang YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1609-15. PubMed ID: 20030958
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
Gómez-Almaguer D
Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
[TBL] [Abstract][Full Text] [Related]
7. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
8. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
9. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
10. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches to refractory immune thrombocytopenic purpura.
Bussel JB
Blood Rev; 2002 Mar; 16(1):31-6. PubMed ID: 11913991
[TBL] [Abstract][Full Text] [Related]
12. [Current treatment of primary immune thrombocytopenia].
Lozano ML; Vicente V
Med Clin (Barc); 2014 May; 142(9):399-405. PubMed ID: 23809409
[TBL] [Abstract][Full Text] [Related]
13. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Liebman HA
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
[TBL] [Abstract][Full Text] [Related]
14. [New treatment methods for autoimmune thrombocytopenia].
Koene HR
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2609-14. PubMed ID: 18161261
[TBL] [Abstract][Full Text] [Related]
15. Management of chronic immune thrombocytopenic purpura in children and adults.
Blanchette V; Freedman J; Garvey B
Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenic purpura.
Psaila B; Bussel JB
Hematol Oncol Clin North Am; 2007 Aug; 21(4):743-59, vii. PubMed ID: 17666288
[TBL] [Abstract][Full Text] [Related]
17. Management of immune thrombocytopenic purpura in adults.
Stasi R; Provan D
Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acute immune thrombocytopenic purpura.
Tarantino MD; Goldsmith G
Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
[TBL] [Abstract][Full Text] [Related]
19. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
Aggarwal A; Catlett JP
South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
[TBL] [Abstract][Full Text] [Related]
20. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
